Winner Medical Co Financials
| 300888 Stock | 34.97 0.23 0.65% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 1.6 B | 938.9 M |
|
|
Winner | Select Account or Indicator |
Understanding current and past Winner Medical Co Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Winner Medical Co's financial statements are interrelated, with each one affecting the others. For example, an increase in Winner Medical Co's assets may result in an increase in income on the income statement.
Please note, the presentation of Winner Medical Co's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Winner Medical Co's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Winner Medical Co's management manipulating its earnings.
Winner Medical Co Stock Summary
Winner Medical Co competes with Nanjing Putian, Shenzhen Hifuture, Tianjin Realty, Shenyang Huitian, and Jiangsu Xinning. Winner MedicalCo is entity of China. It is traded as Stock on SHE exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | China Stock View All |
| Exchange | Shenzhen Stock Exchange |
| ISIN | CNE1000047Z8 |
| Business Address | Building No2, Huilong |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.winnermedical.com |
| Phone | 86 75 5281 38888 |
You should never invest in Winner Medical Co without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Winner Stock, because this is throwing your money away. Analyzing the key information contained in Winner Medical Co's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Winner Medical Co Key Financial Ratios
Winner Medical Co's financial ratios allow both analysts and investors to convert raw data from Winner Medical Co's financial statements into concise, actionable information that can be used to evaluate the performance of Winner Medical Co over time and compare it to other companies across industries.| Revenue | 8.19 B | ||||
| Gross Profit | 5.38 B | ||||
| EBITDA | 766.7 M | ||||
| Net Income | 580.4 M | ||||
| Total Asset | 17.11 B |
Winner Medical Co Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 4.5B | 13.0B | 13.3B | 18.2B | 17.1B | 10.4B | |
| Other Current Liab | 205.5M | 1.3B | 816.2M | 1.5B | 19.7M | 18.7M | |
| Other Liab | 46.7M | 107.1M | 123.0M | 241.0M | 277.2M | 291.1M | |
| Net Tangible Assets | 3.0B | 10.2B | 10.4B | 9.6B | 11.1B | 6.2B | |
| Retained Earnings | 1.8B | 5.5B | 6.0B | 7.2B | 6.6B | 4.1B | |
| Accounts Payable | 735.8M | 756.0M | 770.7M | 1.1B | 1.4B | 904.7M | |
| Cash | 480.8M | 4.2B | 4.3B | 4.5B | 4.7B | 2.7B | |
| Other Assets | 253.8M | 328.3M | 413.1M | 422.0M | 485.3M | 309.5M | |
| Net Receivables | 1.0B | 844.3M | 1.1B | 932.6M | 768.6M | 827.7M | |
| Inventory | 992.4M | 1.2B | 1.6B | 1.6B | 1.4B | 1.2B | |
| Other Current Assets | 180.6M | 159.2M | 179.1M | 348.3M | 383.2M | 213.7M | |
| Total Liab | 1.4B | 2.5B | 2.6B | 6.1B | 5.0B | 2.9B | |
| Short Long Term Debt | 294.6M | 120M | 150.1M | 2.3B | 1.5B | 755.6M | |
| Total Current Assets | 2.7B | 11.0B | 10.3B | 12.1B | 10.6B | 7.1B | |
| Intangible Assets | 131.7M | 208.3M | 265.7M | 1.0B | 995.2M | 1.0B | |
| Net Invested Capital | 3.4B | 10.6B | 10.7B | 14.0B | 13.2B | 9.0B | |
| Net Working Capital | 1.5B | 8.6B | 8.3B | 6.6B | 6.3B | 5.1B |
Winner Medical Co Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Tax Provision | 91.2M | 679.9M | 225.3M | 245.3M | 121.3M | 222.6M | |
| Net Interest Income | (19.6M) | 20.8M | 106.9M | 70.5M | 69.5M | 73.0M | |
| Interest Income | 9.1M | 26.2M | 138.0M | 123.9M | 133.9M | 140.6M | |
| Interest Expense | 24.9M | 3.6M | 30.0M | 50.0M | 63.4M | 66.6M | |
| Total Revenue | 4.6B | 12.5B | 8.0B | 11.4B | 8.2B | 7.5B | |
| Gross Profit | 2.4B | 7.5B | 4.0B | 5.4B | 4.0B | 3.9B | |
| Operating Income | 637.2M | 5.0B | 1.3B | 2.2B | 938.9M | 1.6B | |
| Ebit | 594.0M | 4.8B | 1.1B | 2.2B | 2.5B | 1.6B | |
| Research Development | 155.2M | 411.4M | 298.2M | 487.6M | 322.1M | 266.8M | |
| Cost Of Revenue | 2.2B | 5.1B | 4.0B | 6.0B | 4.2B | 3.7B | |
| Income Before Tax | 638.4M | 4.5B | 1.5B | 1.9B | 749.8M | 1.5B | |
| Net Income | 546.3M | 3.8B | 1.2B | 1.7B | 580.4M | 551.4M | |
| Income Tax Expense | 91.2M | 679.9M | 225.3M | 245.3M | 282.1M | 235.4M | |
| Minority Interest | 3.2M | 14.5M | 1.9M | (23.6M) | (48.1M) | (45.7M) | |
| Ebitda | 766.7M | 4.7B | 1.9B | 2.5B | 2.8B | 2.0B |
Winner Medical Co Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Winner Medical Co. It measures of how well Winner is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Winner Medical Co brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Winner had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Winner Medical Co has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (170.4M) | (365.6M) | (473.6M) | (73.5M) | (53.1M) | (55.8M) | |
| Change In Cash | 83.7M | 3.7B | (61.1M) | 282.2M | 306.5M | 291.2M | |
| Net Borrowings | (40.4M) | (109.2M) | (150M) | 2.1B | 2.4B | 2.6B | |
| Depreciation | 103.4M | 158.6M | 370.9M | 481.7M | 540.4M | 567.4M | |
| Dividends Paid | 43.1M | 102.3M | 768.2M | 401.0M | 821.6M | 862.7M | |
| Capital Expenditures | 446.9M | 573.3M | 743.3M | 1.2B | 753.1M | 711.2M | |
| Net Income | 546.3M | 3.8B | 1.2B | 1.7B | 580.4M | 551.4M | |
| End Period Cash Flow | 459.2M | 4.1B | 4.1B | 4.4B | 4.7B | 2.6B | |
| Change To Netincome | 7.3M | 280.1M | (115.8M) | 339.4M | 390.3M | 409.8M | |
| Free Cash Flow | 152.9M | 4.2B | 128.4M | 1.8B | 310.3M | 294.7M | |
| Other Non Cash Items | 62.2M | 97.8M | (6.9M) | 29.6M | 19.0M | 33.2M |
Winner Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Winner Medical Co's current stock value. Our valuation model uses many indicators to compare Winner Medical Co value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Winner Medical Co competition to find correlations between indicators driving Winner Medical Co's intrinsic value. More Info.Winner Medical Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Winner Medical Co by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Winner Medical Co's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Winner Medical Co Systematic Risk
Winner Medical Co's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Winner Medical Co volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Winner Medical Co correlated with the market. If Beta is less than 0 Winner Medical Co generally moves in the opposite direction as compared to the market. If Winner Medical Co Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Winner Medical Co is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Winner Medical Co is generally in the same direction as the market. If Beta > 1 Winner Medical Co moves generally in the same direction as, but more than the movement of the benchmark.
Winner Medical Co Total Assets Over Time
Winner Medical Co Thematic Clasifications
Winner Medical Co is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Winner Medical Co December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Winner Medical Co help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Winner Medical Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Winner Medical Co based on widely used predictive technical indicators. In general, we focus on analyzing Winner Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Winner Medical Co's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.48 | |||
| Information Ratio | 0.1364 | |||
| Maximum Drawdown | 34.27 | |||
| Value At Risk | (2.53) | |||
| Potential Upside | 6.18 |
Complementary Tools for Winner Stock analysis
When running Winner Medical Co's price analysis, check to measure Winner Medical Co's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Winner Medical Co is operating at the current time. Most of Winner Medical Co's value examination focuses on studying past and present price action to predict the probability of Winner Medical Co's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Winner Medical Co's price. Additionally, you may evaluate how the addition of Winner Medical Co to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |